Simplex Trading’s Precision BioSciences DTIL Stock Holding History

Simplex Trading’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-200	Closed	-$832	–	9313
2025 Q4	$832	Buy	+200	New	+$1.14K	﹤0.01%	8068
2022 Q4	–	Sell	-57	Closed	-$2K	–	9433
2022 Q3	$2K	Sell	57 -346	-86%	-$16.4K	﹤0.01%	9258
2022 Q2	$19K	Buy	403 +366	+989%	+$21.5K	﹤0.01%	7658
2022 Q1	$3K	Sell	37 -173	-82%	-$23.5K	﹤0.01%	9679
2021 Q4	$46K	Buy	210 +107	+104%	+$29.9K	﹤0.01%	7363
2021 Q3	$39K	Buy	103 +6	+6%	+$2.03K	﹤0.01%	7814
2021 Q2	$36K	Buy	97 +92	+1,840%	+$27.6K	﹤0.01%	8024
2021 Q1	$166K	Buy	+5	New	+$1.75K	﹤0.01%	5034
2020 Q2	–	Sell	-1	Closed	-$22K	–	7746
2020 Q1	$22K	Hold	1	–	–	﹤0.01%	5864
2019 Q4	$40K	Buy	+1	New	+$314	﹤0.01%	5400

Other funds holding DTIL

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Simplex Trading's DTIL Position: Q1 2026 in Review

Simplex Trading increased its Precision BioSciences (DTIL) stake by 2.9% in Q1 2026, buying an estimated $457 and bringing the position to 3,512 shares worth $19.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6809.

Simplex Trading first reported a position in DTIL in Q1 2020 and has held it in 14 quarters since. The position peaked at $69K in Q3 2021. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

Simplex Trading held 3,512 shares of Precision BioSciences worth $19.3K as of Q1 2026.
Simplex Trading bought 99 Precision BioSciences shares in Q1 2026, an estimated $457.
Precision BioSciences made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6809 holding.
Simplex Trading first reported a position in Precision BioSciences in Q1 2020 and has held it in 14 quarters since.
Simplex Trading's Precision BioSciences position peaked at $69K in Q3 2021.
78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.